Release Date: 10/08/16 12:50 Summary: Renounceable Rights Offer Closure / Notice of Shortfall-SMC.AX Price Sensitive: Yes Download Document 87.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%